ARL5AP2

Across TCGA pan-cancer cohorts, ARL5AP2 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated ARL5AP2 data layer.

The strongest signal is observed in thymoma (THYM), where higher ARL5AP2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ARL5AP2 expression acts as an unfavorable survival marker, although some lineages such as OV and COAD show a favorable association.

THYM, OV, and PAAD are the cancer types where ARL5AP2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Tertile	All	0.310	0.893	<.001	54	view →
OV	DFS	Tertile	IV	0.689	0.376	.001	46	view →
PAAD	DFS	Tertile	All	0.072	0.509	<.001	45	view →
UVM	OS	Tertile	III,IV	0.104	0.813	.001	27	view →
PCPG	OS	Tertile	All	0.505	0.945	.001	18	view →
STAD	OS	Tertile	II,III,IV	0.568	0.753	.017	15	view →
COAD	DFS	Tertile	All	1.000	0.462	.022	12	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

ARL5AP2–THYM (OS)

Open the THYM breakdown →